On Cancer: Targeted Therapy

and/or

91 Blog posts found

In The Clinic

Analyzing Spinal Fluid Could Guide Brain Tumor Diagnosis and Treatment

Cancer DNA taken from spinal fluid could serve as a liquid biopsy that provides information on brain tumor mutations.

MRI of brain and spinal fluid in green

Feature

Remembering John Mendelsohn, a Pioneer of Targeted Therapy for Cancer

The scientific world lost one of its greats this week. Here, we reflect on his influence.

John Mendelsohn

In the Clinic

Liquid Biopsy Is Effective at Guiding Treatment of Lung Cancer, Study Finds

The initial results of an ongoing study show that a liquid biopsy has advantages over a tissue biopsy for people with lung cancer.

A tube of blood superimposed on a lung and a DNA helix

Feature

First Targeted Cancer Drug Approved Based on Mutation Rather than Tumor Type

Learn about larotrectinib, the first cancer drug to be FDA approved for adult and pediatric patients at the same time.

MSK medical oncologist Alexander Drilon

Q&A

What’s Behind the Rise in Liver Cancer Deaths — and What Can Be Done About It?

Find out what’s contributing to a marked increase in the death rate for liver cancer.

Illustration of liver inside human torso with other organs (intestines) also visible.

Feature

What Really Matters in Treating Brain Cancer: An Interview with Two MSK Experts

Two of MSK's top brain experts reflect on how they care for people and recent advances in treatment.

Viviane Tabar and Lisa DeAngelis

Feature

The Treatments Changing Childhood Cancer: At Work with Filemon Dela Cruz

Go behind the scenes with Filemon Dela Cruz, who cares for children with sarcoma and conducts precision medicine research at Memorial Sloan Kettering.

MSK pediatric oncologist Filemon Dela Cruz

In the Clinic

Taking on Mantle Cell Lymphoma: MSK Leads Research into New Treatments

Learn about novel therapies emerging for the treatment of mantle cell lymphoma.

MSK medical oncologist Anita Kumar